What Is an SMA Blood Test and What Does It Measure?

An SMA blood test is a multi-channel chemistry panel that measures several substances in your blood simultaneously from a single sample. “SMA” stands for Sequential Multiple Analysis, a name that dates back to the automated analyzers introduced in clinical laboratories in the 1960s and 1970s. Today, the tests once grouped under the SMA label live on as the Basic Metabolic Panel (BMP) and the Comprehensive Metabolic Panel (CMP), though some labs and older physicians still use the SMA terminology. The panel gives a broad snapshot of how your kidneys, liver, electrolytes, and blood sugar are doing, which is why it remains one of the most commonly ordered sets of lab work in routine medical care.

Where the Name Comes From

The SMA designation originated with the Technicon AutoAnalyzer, a machine that revolutionized clinical chemistry by automating what had previously been done by hand, one test at a time. The number after “SMA” indicated how many tests the machine ran simultaneously. An SMA-4 measured four parameters in a single pass. An SMA-12 ran twelve. One widely used configuration, the SMA 12/60, could process 60 samples per hour across a panel of tests.

Early evaluations of these instruments focused on whether the automation was precise enough to trust. A study of the SMA-4 found the machine’s precision was strong, with a mean coefficient of variation under 1% for haematocrit and agreement within about 2% of manual methods for most results.¹ The SMA 12/60 became a workhorse of clinical chemistry in the 1970s, and large studies used it to establish normal ranges for common blood chemicals across different age groups and sexes, drawing on samples from over a thousand clinically normal adults across multiple regions of the United States.²

By the 1980s, newer instruments replaced the Technicon machines, but the concept of a bundled chemistry panel stuck. The American Medical Association eventually standardized these bundles into what we now call the BMP (typically 8 tests) and CMP (typically 14 tests). If your lab slip says “SMA-7” or “SMA-20,” it is using the older naming convention for what is functionally the same thing as a modern metabolic panel.

What the Panel Actually Measures

The specific tests included depend on which version of the panel your doctor orders. A basic panel covers your blood sugar, kidney function markers, and electrolyte balance. A comprehensive panel adds liver-related tests and protein levels. Here is what those individual measurements tell you:

Glucose: Your blood sugar level at the time of the draw. Elevated fasting glucose can signal diabetes or prediabetes; abnormally low glucose can indicate other metabolic problems.
BUN (blood urea nitrogen): A waste product filtered by your kidneys. Higher levels can suggest the kidneys are not filtering efficiently, though dehydration and high-protein diets can also push BUN up.
Creatinine: Another kidney filtration marker. Creatinine comes from normal muscle metabolism, and your kidneys are supposed to clear it at a steady rate. An elevated level is one of the earliest flags for kidney trouble.
Sodium, potassium, chloride, and bicarbonate: These electrolytes keep your nerve signals firing, your muscles contracting, and your blood’s acid-base balance in check. Even modest shifts in potassium, for instance, can affect heart rhythm.
Calcium: Important for bones, muscles, and nerve function. Most panels report total calcium, which includes both the active form and the portion bound to proteins like albumin.

Comprehensive panels add a second tier of results:

Albumin and total protein: Albumin is the most abundant protein in your blood and serves as a rough indicator of liver function and nutritional status. Total protein combines albumin with globulins, which play roles in immune function and inflammation.
Liver enzymes (ALT, AST, ALP): These enzymes leak into the bloodstream when liver cells are damaged or bile flow is obstructed. Patterns in which enzymes are elevated help doctors distinguish between different types of liver injury.
Bilirubin: A byproduct of red blood cell breakdown that the liver processes. Elevated bilirubin can cause jaundice and points toward liver disease, bile duct obstruction, or excessive red blood cell destruction.

BUN, Creatinine, and What the Ratio Reveals

Two of the most clinically useful numbers on your SMA panel are BUN and creatinine, and doctors look at them both individually and in relation to each other. A review of renal function markers notes that BUN and creatinine are best interpreted together, paying attention to their absolute levels and to the ratio between them.³ The BUN-to-creatinine ratio is particularly helpful because it can distinguish between different causes of kidney stress. When BUN rises disproportionately compared to creatinine, the problem is often happening before the kidney itself, such as dehydration or reduced blood flow, rather than damage within the kidney.⁴

This ratio has applications beyond kidney disease. In patients hospitalized with heart failure, a higher BUN-to-creatinine ratio at admission was associated with greater odds of kidney function improving during treatment. Researchers found roughly 40-50% greater odds of renal recovery for every 10-point increase in the ratio, suggesting that the kidney dysfunction in those patients was driven by poor blood flow rather than permanent damage.⁵ In practical terms, the BUN-to-creatinine ratio helps your doctor figure out not just whether something is wrong, but whether the underlying cause is likely to respond to treatment.

The Anion Gap, a Calculated Bonus

Your SMA panel also generates a value that is not directly measured but calculated from the electrolyte results: the anion gap. It compares the concentration of sodium against the combined concentrations of chloride and bicarbonate. The difference reflects unmeasured charged particles in your blood, and shifts in that gap point toward specific medical problems.

The anion gap has been used for decades to evaluate acid-base disorders, identify potential errors in electrolyte measurements, and even detect unusual proteins in the blood.⁶ When the anion gap is elevated, it signals that acids are accumulating in the blood. This narrows the diagnostic possibilities considerably. Common culprits include diabetic ketoacidosis, kidney failure, lactic acidosis from severe infection or shock, and poisoning from substances like methanol or ethylene glycol.⁷

An unusually low or even negative anion gap is also informative, since it can suggest certain clinical conditions or raise a flag that the electrolyte measurements themselves might be off.⁷ The traditional reference range of 8 to 16 mmol/L was established with older laboratory equipment, and research using more modern electrode-based analyzers has suggested this range may need updating, since newer instruments tend to measure chloride slightly differently.⁸ If you see an anion gap value on your lab report, keep in mind that the “normal” range your lab uses may differ from what older textbooks cite.

Reference Ranges Are Not Universal

One of the most common sources of confusion with SMA panel results is the reference range printed alongside each value. Those ranges are not carved in stone. They vary between laboratories depending on the instruments and methods used, which is why two labs can draw blood from the same person and report slightly different “normal” cutoffs. Your doctor typically interprets your results against the specific ranges provided by the lab that processed your sample, not against a generic textbook range.

Age, sex, and ethnicity also affect what counts as normal. The original SMA 12/60 studies in the 1970s already showed that normal ranges for many blood chemicals differ between men and women and shift with age.² Ethnicity adds another layer. For example, vitamin D levels tend to be lower in people of African descent even when bone health is comparable, because genetically determined differences in vitamin D binding proteins affect total measured levels without necessarily reflecting a true deficiency.⁹ The broader lesson is that a value slightly outside the printed range does not automatically mean something is wrong. Context matters, and a single out-of-range result on one draw is often repeated before any action is taken.

Fasting, Medications, and Hemolysis

If your doctor tells you to fast before a blood draw, it is because eating can change several of the values on your SMA panel. Food intake triggers metabolic and hormonal shifts from the absorption of sugars, fats, and proteins, and the degree of those shifts varies depending on what you ate, when you ate it, and individual factors like smoking and coffee consumption.¹⁰ Glucose is the most obvious test affected by eating, but triglycerides, potassium, and phosphorus can also shift after a meal. A standard overnight fast of 8 to 12 hours keeps these variables from muddying the results.

Medications present a less visible problem. The prevalence of drug interactions with lab tests may be as high as 43% of patients, meaning that drugs you are taking can push certain lab values up or down in ways that have nothing to do with disease.¹¹ Some of these interactions are chemical, where the drug directly reacts with the assay reagent and produces a misleading number. Others are physiological, where the drug genuinely alters the substance being measured, such as diuretics lowering potassium. This is why your provider should know what medications you have taken in the days leading up to a blood draw. Unrecognized drug interference can lead to unnecessary follow-up testing or, worse, incorrect treatment decisions.

Even the blood sample itself can cause problems before it reaches the analyzer. Hemolysis, where red blood cells rupture and release their contents into the serum, is a common preanalytical issue. When a sample is hemolyzed, the enzymes and other substances normally sealed inside red cells leak out and contaminate the results. Certain enzyme levels are especially vulnerable, with lactate dehydrogenase being the most dramatically affected, though the degree of interference depends on both the amount of hemolysis and the method the lab uses.¹² If your lab report notes that a sample was hemolyzed, some of the values may not be reliable, and a redraw might be necessary.

Why Calcium Ended Up on Every Panel

If you have ever wondered why calcium appears on a routine blood panel even when nobody suspects a calcium problem, there is a straightforward explanation: it was bundled into the standardized panel approved by the American Medical Association, and once bundled, it gets ordered every time the panel is ordered, regardless of clinical suspicion. A study examining the effects of including calcium in standard panels found that total test volumes for calcium increased more than threefold after it was added to the BMP and CMP, with the vast majority of those calcium tests being ordered as part of the panel rather than individually.¹³ The study also found that the rate of calcium-related diagnoses did not change significantly after the bundling, raising questions about whether routine calcium screening in asymptomatic patients adds meaningful clinical value.

This is a good illustration of how SMA-style panels work in practice. The appeal of bundled testing is efficiency: one tube of blood, one run through the analyzer, a dozen or more results at once for a relatively low cost. The trade-off is that you sometimes get results nobody asked for, and an out-of-range calcium result on a routine panel can trigger additional testing, imaging, or specialist referrals that may not have been warranted. When you see your panel results, keep in mind that some of the tests were performed because they were part of the bundle, not because your doctor specifically wanted that particular value checked.

The Albumin-to-Globulin Ratio

Comprehensive panels report albumin and total protein, and from those two numbers your lab calculates the albumin-to-globulin ratio. This ratio is a quick way to gauge the balance between the two main protein groups in your blood. Albumin is produced by the liver and tends to drop when the liver is struggling or when chronic illness is draining the body’s reserves. Globulins include immune system proteins and tend to rise during inflammation or infection.

A flipped ratio, where globulin is higher than albumin, can be a nonspecific marker that something inflammatory or immunological is going on. Research has explored the diagnostic value of this ratio in settings ranging from liver disease to joint infections. In one study looking at suspected infections around prosthetic joints, higher globulin levels and a lower albumin-to-globulin ratio were strongly associated with infection, and both markers showed reasonable diagnostic accuracy with sensitivities approaching 65-79% and specificities in a similar range.¹⁴ On its own, the ratio is not specific enough to diagnose any single condition, but it adds a useful data point that can prompt further investigation.

Avoiding the SMA Name Trap

One source of genuine confusion is that “SMA” means completely different things depending on context. In lab chemistry, it refers to Sequential Multiple Analysis. In neurology, SMA stands for spinal muscular atrophy, a genetic disorder affecting motor neurons, and testing for it involves genetic analysis of the SMN1 gene, not blood chemistry. In gastroenterology and liver pathology, SMA can refer to smooth muscle antibodies, which are autoantibodies used to help diagnose autoimmune hepatitis and other conditions. If you are reading a lab result or medical discussion that mentions “SMA,” the context should make it clear which meaning is intended. A chemistry panel and a genetic test for a neuromuscular disease are obviously not the same thing, but the shared abbreviation has caused real misunderstandings when patients search for their results online.

Point-of-Care Testing and Speed

The traditional workflow for an SMA-style panel involves drawing blood, sending it to a central laboratory, and waiting for results. In emergency departments, that wait can delay diagnosis and treatment decisions. Point-of-care testing devices bring a miniaturized version of the chemistry analyzer to the patient’s bedside, producing metabolic panel results in minutes rather than the hour or more that central lab processing typically takes.

Studies show this speed translates into tangible benefits. A randomized trial in an emergency department found that using a point-of-care comprehensive metabolic panel reduced the median time patients spent in the ED by about 22 minutes compared to sending samples to the central lab.¹⁵ Twenty-two minutes may sound modest, but across hundreds of patients per day in a busy ED, that time savings adds up significantly and frees beds for the next patient. A separate study confirmed that bedside point-of-care chemistry testing significantly reduced turnaround times for critically ill ED patients across all tested analytes.¹⁶

The accuracy of point-of-care devices has improved markedly over the years, though they still have limitations. Most are best suited for screening and urgent decision-making rather than replacing the full precision of a central laboratory. When a point-of-care result looks abnormal, it is common practice to confirm it with a conventional lab draw. Still, for settings where speed matters, having a metabolic panel result in hand within minutes instead of waiting an hour changes how care is delivered. It is a direct descendant of the original SMA concept: get multiple results fast from one sample, so doctors can make decisions sooner.

When Your Doctor Wants More Than the Standard Panel

The SMA panel, whether you call it a BMP, CMP, or chem-7, covers the basics. But there are situations where additional tests are needed to complete the picture. Thyroid function, lipid profiles, hemoglobin A1c for long-term blood sugar control, and specialized liver tests like GGT (gamma-glutamyl transferase) are not part of the standard metabolic panel and must be ordered separately. If your doctor is investigating a specific symptom or monitoring a known condition, you may see these add-on tests requested alongside your standard chemistry panel.

There is also a practical consideration about how often panels should be repeated. In stable, healthy adults, annual metabolic panels during routine physicals are common but not always necessary. In contrast, someone on medications that affect kidney function or electrolytes, such as certain blood pressure drugs or diuretics, may need panels checked every few months. The frequency is driven by clinical need, not by a one-size-fits-all schedule. If you are unsure why a panel was ordered or what a particular out-of-range value means for you specifically, asking your provider to walk through the results is almost always more productive than trying to interpret them through reference range charts alone.

1
Europe PMC. An evaluation of the autoanalyzer SMA-4
2
Oxford Academic (Clinical Chemistry). Estimation of Normal Ranges from a Controlled Sample Survey. I. Sex- and Age-Related Influence on the SMA 12/60 Screening Group of Tests
3
Emergency Medicine Clinics of North America. Blood Urea Nitrogen and Creatinine
4
PubMed Central. Markers of renal function tests
5
PubMed Central. Blood urea nitrogen/creatinine ratio identifies a high-risk but potentially reversible form of renal dysfunction in patients with decompensated heart failure
6
PubMed Central. The serum anion gap in the evaluation of acid-base disorders: what are its limitations and can its effectiveness be improved?
7
PubMed. Approach to Patients With High Anion Gap Metabolic Acidosis: Core Curriculum 2021
8
JAMA Internal Medicine. The Fall of the Serum Anion Gap
9
The Journal of the American Board of Family Medicine. Interpretating Normal Values and Reference Ranges for Laboratory Tests
10
PubMed. Standardization of collection requirements for fasting samples
11
PubMed Central. Drug interference with biochemical laboratory tests
12
Clinical Chemistry. Effect of in vitro hemolysis on chemical values for serum
13
Oxford Academic (Clinical Chemistry). Is It Time to Remove Total Calcium from the Basic and Comprehensive Metabolic Panels? Assessing the Effects of American Medical Association-Approved Chemical Test Panels on Laboratory Utilization
14
BioMed Central. Serum globulin and albumin to globulin ratio as potential diagnostic biomarkers for periprosthetic joint infection: a retrospective review
15
PubMed. Use of a comprehensive metabolic panel point-of-care test to reduce length of stay in the emergency department: a randomized controlled trial
16
PubMed. Comprehensive bedside point of care testing in critical ED patients: a before and after study